Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.

We have produced adriamycin (ADM)-resistant variants of the human lung cancer cell lines NCI-H69 (small cell), MOR (adenocarcinoma) and COR-L23 (large cell) but have failed to produce resistant variants of two other small cell lines. In each case, the derivation protocol took 7-9 months and included...

Descripción completa

Detalles Bibliográficos
Autores principales: Twentyman, P. R., Fox, N. E., Wright, K. A., Bleehen, N. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1986
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001423/
https://www.ncbi.nlm.nih.gov/pubmed/3011054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001423/
https://www.ncbi.nlm.nih.gov/pubmed/3011054

Ejemplares similares